LABA without ICS in asthma — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Contact the prescriber because LABA monotherapy is inappropriate in asthma
Long-acting beta2 agonists should not be used without inhaled corticosteroid therapy in asthma because this increases risk of poor outcomes. The patient also has symptoms suggesting poor control. The pharmacist should contact the prescriber to ensure an appropriate ICS-containing regimen is used.
Reference: BNF; NICE CKS